Search Results - "Kavurgaci, Suna"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    The Success of Noninvasive Mechanical Ventilation in Relation with Concomitant Disorders in Copd Patients with Acute Hypercapnic Respiratory Failure by Kavurgacı, Suna

    Published in Lokman Hekim Health Sciences (01-03-2023)
    “…Introduction: Although the benefit of non-invasive mechanical ventilation (NIMV) has been proven in the management of acute exacerbations of chronic…”
    Get full text
    Journal Article
  2. 2

    Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study by Ergür, Figen Öztürk, Yıldız, Murat, Şener, Melahat Uzel, Kavurgacı, Suna, Ozturk, Ayperi

    Published in São Paulo medical journal (01-05-2022)
    “…Favipiravir is generally used in treating coronavirus disease 2019 (COVID-19) pneumonia in Turkey. To determine the side effects of favipiravir and whether it…”
    Get full text
    Journal Article
  3. 3

    Evaluation of Chemoradiotherapy Toxicity in Geriatric Patients Diagnosed with Locally Advanced Non-Small Cell Lung Cancer by Derya Kizilgöz, Pınar Akın Kabalak, Suna Kavurgacı, Ülkü Yılmaz

    Published in International Journal of Gerontology (01-10-2023)
    “…Background: Geriatric patients diagnosed with locally advanced lung cancer often cannot access appropriate treatment options due to the increasing prevalence…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The Clinical Impact of Re-biopsies in Lung Adenocarcinoma: a Retrospective Multicenter Study by Kabalak, Pınar Akın, Kızılgöz, Derya, Kavurgacı, Suna, Demirci, Nilgün Yılmaz, Yılmaz, Şenay, Ak, Güntülü, Metintaş, Selma, Metintaş, Muzaffer, Demirağ, Funda, Yılmaz, Ülkü

    Published in Pathology oncology research (01-10-2020)
    “…If a patient’s cancer progresses while undergoing targeted therapy, a re-biopsy is not mandatory. But when evaluating the benefits and risks on a case-by-case…”
    Get full text
    Journal Article
  6. 6
  7. 7

    The clinical utility of the LENT score in patients with malignant pleural mesothelioma by Söyler, Yasemin, Kavurgacı, Suna, Gürel Akan, Ezgi, Yılmaz, Ülkü

    Published in Tüberküloz ve toraks (01-12-2022)
    “…In malignant pleural mesothelioma (MPM), useful tools are needed to predict survival. Thus, we aimed to evaluate the LENT score, and demonstrate the…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Evaluation of mortality predictors in hospitalized COVID-19 patients: Retrospective cohort study by Uzel Şener, Melahat, Yıldız, Murat, Kavurgacı, Suna, Öztürk Ergür, Figen, Şener, Alp, Öztürk, Ayperi

    Published in Tüberküloz ve toraks (01-06-2021)
    “…Evaluation of parameters that will predict prognosis in COVID19 disease ensures correct determination of treatment strategy. In this study, it was aimed to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Clinical features and survival outcomes of unclassified high-grade neuroendocrine carcinoma of the lung by SÖYLER, Yasemin, AKIN KABALAK, Pınar, KAVURGACI, Suna, DEMİRAĞ, Funda, YILMAZ, Ülkü

    Published in Sakarya tıp dergisi (08-06-2023)
    “…Background: Differentiating high-grade neuroendocrine carcinomas (HGNEC) is difficult. We aimed to assess the clinical features and survival outcomes of…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia by Suna, Kavurgacı, Melahat, Uzel Şener, Murat, Yıldız, Figen, Öztürk Ergür, Ayperi, Öztürk

    Published in Medicina clinica (22-04-2022)
    “…Until now, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 2.5 million individuals worldwide, with approximately 170,000 deaths…”
    Get more information
    Journal Article
  15. 15

    Clinical management of lung cancer patients with respiratory symptoms during the COVID-19 pandemic by Kabalak, Pınar Akın, Kızılgöz, Derya, Kavurgacı, Suna, Yılmaz, Ülkü

    “…There are many clinical conditions, such as lung cancer, that need to be followed up and treated during a pandemic. Providing health care for patients who are…”
    Get more information
    Journal Article
  16. 16

    Could PD-L1 positivity be associated with venous thrombosis in patients with non-small cell lung cancer? by Söyler, Yasemin, Akın Kabalak, Pınar, Kavurgacı, Suna, Akyürek, Nalan, Demirağ, Funda, Yılmaz, Ülkü

    Published in Journal of thrombosis and thrombolysis (01-02-2023)
    “…The risk of venous thromboembolism (VTE) is increased in non-small cell lung cancer (NSCLC), and defining at-risk patients is important. Thus, we aimed to…”
    Get full text
    Journal Article
  17. 17

    Clinical features and survival outcomes of unclassified high-grade neuroendocrine carcinoma of the lung by Funda Demirağ, Ülkü Yılmaz, Suna Kavurgacı, Pınar Akın Kabalak, Yasemin Söyler

    Published in Sakarya tıp dergisi (01-06-2023)
    “…Background: Differentiating high-grade neuroendocrine carcinomas (HGNEC) is difficult. We aimed to assess the clinical features and survival outcomes of…”
    Get full text
    Journal Article
  18. 18

    Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia by Suna, Kavurgacı, Melahat, Uzel Şener, Murat, Yıldız, Figen, Öztürk Ergür, Ayperi, Öztürk

    Published in Medicina clínica (English ed.) (22-04-2022)
    “…Until now, the coronavirus disease 2019 (COVID-19) pandemic has affected more than 2.5 million individuals worldwide, with approximately 170,000 deaths…”
    Get full text
    Journal Article
  19. 19

    Adverse effects associated with favipiravir in patients with COVID-19 pneumonia: a retrospective study by Ergür, Figen Öztürk, Yıldız, Murat, Şener, Melahat Uzel, Kavurgacı, Suna, Ozturk, Ayperi

    Published in São Paulo medical journal (2022)
    “…ABSTRACT BACKGROUND: Favipiravir is generally used in treating coronavirus disease 2019 (COVID-19) pneumonia in Turkey. OBJECTIVE: To determine the side…”
    Get full text
    Journal Article
  20. 20